Trials / Completed
CompletedNCT01429207
Capturing Parkinson's Disease Medication Side Effects During Daily Activities
Phase I Study: Monitoring Levodopa-Induced Dyskinesia Using Accelerometer & Gyroscope-based Motion Detection System
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- Great Lakes NeuroTechnologies Inc. · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to test whether body-worn wireless motion sensors can measure dyskinesias (involuntary movements caused by medications) in individuals with Parkinson disease (PD) independent of voluntary activity being performed and other PD motor symptoms (e.g. tremor).
Conditions
Timeline
- Start date
- 2011-08-01
- First posted
- 2011-09-07
- Last updated
- 2012-06-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01429207. Inclusion in this directory is not an endorsement.